hsa-miR-206b Involves in the Development of Papillary Thyroid Carcinoma via Targeting LMX1B

<div>The expression level of hsa-miR-206 and hsa-miR-299-3p was significantly related to prognosis in patients of stage III and stage IV. (a) Kaplan-Meier survival analysis of hsa-miR-206 expression level stratified by stage III_IV and stage I_II patients. (b) Kaplan-Meier survival analysis of hsa-miR-299-3p expression level stratified by stage III_IV and stage I_II patients.</div>

BioMed Research International

fig3

Figure 3

Figure 3: hsa-miR-206b Involves in the Development of Papillary Thyroid Carcinoma via Targeting LMX1B 